The Role of Progesterone Membrane Receptors in the Development of Gestational Diabetes Mellitus
2 other identifiers
observational
90
1 country
1
Brief Summary
The aim of this study is to investigate the potential roles of PGRMC1, PGRMC2, and PAQR family membrane progesterone receptors in the pathophysiology of gestational diabetes mellitus by comparing their expression levels in placentas from pregnancies complicated by gestational diabetes mellitus with those from healthy pregnancies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
July 29, 2026
CompletedFirst Posted
Study publicly available on registry
August 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
August 6, 2026
August 1, 2026
1 year
July 29, 2026
August 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
1. Placental PGRMC1,PGRMC2 and PAQR mRNA expression levels
Relative placental mRNA expression levels of PGRMC1, PGRMC2 and PAQR family receptors measured by quantitative real-time polymerase chain reaction (qRT-PCR) in placental tissue collected immedia
Delivery
Study Arms (2)
Gestational diabetes mellitus group
Control Group
Gestational diabetes mellitus group and control group
Gestational diabetes mellitusGroupPregnant women diagnosed with gestational diabetes who will undergo placental tissue collection at delivery for molecularanalysis. Healthy Control GroupHealthy pregnant women with normal oral glucose tolerence test result who will undergo placental tissue collection at delivery for molecular analysis.
Eligibility Criteria
Pregnant women aged 18-45 years delivering at Samsun City Hospital will be enrolled. The study population will consist of women with singleton pregnancies complicated by gestational diabetes mellitus and healthy pregnant women with appropriate fetal growth serving as the control group. Placental tissue samples will be collected immediately after delivery for molecular analysis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsun City Hospital
Samsun, Turkey (Türkiye)
Related Publications (1)
Arck P, Hansen PJ, Mulac Jericevic B, Piccinni MP, Szekeres-Bartho J. Progesterone during pregnancy: endocrine-immune cross talk in mammalian species and the role of stress. Am J Reprod Immunol. 2007 Sep;58(3):268-79. doi: 10.1111/j.1600-0897.2007.00512.x.
PMID: 17681043RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
SEMRA EROGLU
Samsun University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2026
First Posted
August 6, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2027
Last Updated
August 6, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL